Cargando…

The Role of Long Non-Coding RNA NNT-AS1 in Neoplastic Disease

SIMPLE SUMMARY: Nicotinamide nucleotide transhydrogenase-antisense 1 (NNT-AS1), which is a newly-discovered long non-coding RNA (lncRNA), has been found to be dysregulated in a variety of neoplastic diseases. With the accumulation of studies on NNT-AS1 in recent years, the mechanism of NNT-AS1 and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Cong, Duan, Shiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690676/ https://www.ncbi.nlm.nih.gov/pubmed/33113895 http://dx.doi.org/10.3390/cancers12113086

Ejemplares similares

Long non-coding RNA NNT-AS1 positively regulates NPM1 expression to affect the proliferation of estrogen-mediated endometrial carcinoma by interacting
por: Shen, Jie, et al.
Publicado: (2022)

Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma
por: Huang, Lining, et al.
Publicado: (2019)

Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203
por: Gu, Yulei, et al.
Publicado: (2020)

LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis
por: Liu, Yanjie, et al.
Publicado: (2020)

Antisense lncRNA NNT-AS1 promoted esophageal squamous cell carcinoma progression by regulating its sense gene NNT expression
por: Pan, Xianglong, et al.
Publicado: (2022)

Long non‐coding RNA NNT‐AS1 sponges miR‐424/E2F1 to promote the tumorigenesis and cell cycle progression of gastric cancer
por: Chen, Beibei, et al.
Publicado: (2018)

NNT in NSCLC: No need to worry?
por: Conrad, Marcus
Publicado: (2020)

Long Non-Coding RNA NNT-AS1 Contributes to Cisplatin Resistance via miR-1236-3p/ATG7 Axis in Lung Cancer Cells
por: Wang, Haifeng, et al.
Publicado: (2020)

The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis
por: Zhou, Yadi, et al.
Publicado: (2021)

The Multiple Roles of Periostin in Non-Neoplastic Disease
por: Yang, Lina, et al.
Publicado: (2022)

The emerging roles of long non‐coding RNAs in polyglutamine diseases
por: Dong, Xiaoyu, et al.
Publicado: (2021)

Nrf2 in Neoplastic and Non-Neoplastic Liver Diseases
por: Orrù, Claudia, et al.
Publicado: (2020)

Serum long non-coding RNA NNT-AS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR-496/RAP2C axis in colorectal cancer
por: Yin, Hua, et al.
Publicado: (2021)

Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo
por: Wang, Qian, et al.
Publicado: (2016)

Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis
por: Lu, Ye-Bin, et al.
Publicado: (2017)

Long non-coding RNA NNT-AS1 knockdown represses the progression of gastric cancer via modulating the miR-142-5p/SOX4/Wnt/β-catenin signaling pathway
por: Zhang, Jianfeng, et al.
Publicado: (2020)

The Role of Micro RNA and Long-Non-Coding RNA in Osteoporosis
por: Ko, Nai-Yu, et al.
Publicado: (2020)

Using and Interpreting Adjusted NNT Measures in Biomedical Research
por: Bender, Ralf
Publicado: (2010)

Number needed to treat (NNT) in clinical literature: an appraisal
por: Mendes, Diogo, et al.
Publicado: (2017)

The role of long non-coding RNA FGD5-AS1 in cancer
por: He, Na, et al.
Publicado: (2022)

Exosomes in Dogs and Cats: An Innovative Approach to Neoplastic and Non-Neoplastic Diseases
por: Diomaiuto, Emanuela, et al.
Publicado: (2021)

Insight into the divergent role of TRAIL in non‐neoplastic neurological diseases
por: Gao, Shiqi, et al.
Publicado: (2020)

Role of long non-coding RNA H19 in the development of osteoporosis
por: Chen, Senxiang, et al.
Publicado: (2021)

Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression
por: Wu, Deyao, et al.
Publicado: (2019)

Classification, function, and advances in tsRNA in non-neoplastic diseases
por: Zhang, Liou, et al.
Publicado: (2023)

The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases
por: Prinz, Felix, et al.
Publicado: (2019)

Emerging roles of long non‐coding RNA in cancer
por: Sanchez Calle, Anna, et al.
Publicado: (2018)

Emerging roles of the long non-coding RNA NEAT1 in gynecologic cancers
por: Farzaneh, Maryam, et al.
Publicado: (2023)

Rare thyroid non-neoplastic diseases
por: Lacka, Katarzyna, et al.
Publicado: (2015)

Long Non-Coding RNAs in the Cell Fate Determination of Neoplastic Thymic Epithelial Cells
por: Iaiza, Alessia, et al.
Publicado: (2022)

The functional role of long non-coding RNA in human carcinomas
por: Gibb, Ewan A, et al.
Publicado: (2011)

Role of the long non-coding RNA HOTAIR in hepatocellular carcinoma
por: Wu, Liming, et al.
Publicado: (2017)

The role of long non-coding RNA GAS5 in cancers
por: Ji, Jiali, et al.
Publicado: (2019)

Role of the long non-coding RNA LINC00052 in tumors
por: Xiong, Dongmei, et al.
Publicado: (2021)

Critical effects of long non-coding RNA on fibrosis diseases
por: Zhang, Yue, et al.
Publicado: (2018)

Long non-coding RNAs: From disease code to drug role
por: Chen, Yuanyuan, et al.
Publicado: (2021)

Long Non-Coding RNA in Vascular Disease and Aging
por: Bink, Diewertje I., et al.
Publicado: (2019)

The relationships between LncRNA NNT-AS1, CRP, PCT and their interactions and the refractory mycoplasma pneumoniae pneumonia in children
por: Chen, Ping, et al.
Publicado: (2021)

Long Non-Coding RNA in Cancer
por: Hauptman, Nina, et al.
Publicado: (2013)

Long Non-Coding RNA Epigenetics
por: Kazimierczyk, Marek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1v0dbc03hd8kjvq8potfjqha8n